Oral Modified Release Morphine for Breathlessness in Chronic Heart Failure: A Randomized Placebo-Controlled Trial
Miriam J. Johnson(University of Hull), Andrew L. Clark(University of Bedfordshire), Sarah Cockayne(University of York), Kerry Bell(University of York), Rhian Gabe(Cancer Research UK), Stephen G. Oxberry(Hull York Medical School), Laura Jefferson(University of York), Karen Hogg(Glasgow Royal Infirmary), Caroline Fairhurst(University of York), Kate Hicks(University of York), Victoria Allgar(University of York), David Torgerson(University of York), Jeremy J Murphy(Darlington Memorial Hospital), David C. Currow(Flinders University), Justin Ghosh(Scarborough General Hospital), John G.F. Cleland(University of Glasgow)
Cited by 45
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k
Rosuvastatin in Older Patients with Systolic Heart Failure
|New England Journal of Medicine|2007|1.5k